Keywords: Dual trigger; GnRH agonist trigger; IVF; low-dose hCG; OHSS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCG; human chorionic gonadotropin; E2; serum estradiol; P; progesterone; T; testosterone; LH; luteinizing hormone; FSH; follicle-stimulating hormone; ELISA; enzyme-linked immunosorbent assay; ERβ; estrogen receptor beta; IVF; in vitro fertilization; PCOS
Keywords: anti-TPO; Thyroid peroxidase auto-antibodies; ART; Assisted reproduction technology; ASRM; American Society for Reproductive Medicine; ATA; American Thyroid Association; CI; Confidence interval; E2; Estradiol; ES; Endocrine Society; FSH; Follicle stimulat
Keywords: IVM; in vitro maturation; IVF; in vitro fertilization; ART; assisted reproductive technologies; OHSS; ovarian hyperstimulation syndrome; PCOS; polycystic ovary symdromes; ICSI; intracytoplasmic sperm injection; MDI; Mental Development Index; VVM; in vivo
Keywords: fibroids; Mullerian aplasia; POF; OHSS; hypogonadism; Kallmann syndrome; PCOS; endometriosis;
Keywords: OHSS; calcium infusion; RCT; PCO;
Keywords: GnRHa trigger; PCOS; IVF outcomes; OHSS;
Keywords: GnRHa trigger; dual GnRHa trigger; OHSS; luteal phase support; low-dose hCG supplementation;
Keywords: AFE; amniotic fluid embolism; DIC; disseminated intravascular coagulation; HELLP; hemolysis, elevated liver enzymes, and low platelets; HUS; hemolytic uremic syndrome; LDH; lactate dehydrogenase; MMR; maternal mortality rate; OHSS; ovarian hyperstimulatio
Keywords: PCOS; polycystic ovary syndrome; IR; insulin resistance; IVF; in vitro fertilization; NIH; National Institutes of Health; TCA; tricarboxylic acid cycle; BCAAs; branched-chain amino acids; FF; follicular fluid; CCs; cumulus cells; ART; assisted reproductiv
Keywords: freeze-all; GnRH agonist; OHSS; segmentation; trigger;
Keywords: Ovulation induction; luteal phase; human menopausal gonadotropin; letrozole; frozen embryo transfer; LH surge; OHSS
Keywords: antral follicle count; anti-Müllerian hormone; corifollitropin alpha; IVF; OHSS; ovarian stimulation
Keywords: AT; antithrombin; OHSS; ovarian hyperstimulation syndrome; HCG; human chorionic gonadotropin; IVF; in-vitro fertilization; RAS; renin-angiotensin system; VEGF; vascular endothelial growth factor; vW; von Willebrand; VTE; venous thromboembolism; PIATD; pre
Keywords: OHSS; Severe; Prophylaxis; Hespan; PCOS; Non-PCOS
Effects of electroacupuncture on luteal regression and steroidogenesis in ovarian hyperstimulation syndrome model rat
Keywords: Electroacupuncture; OHSS; Neuropeptide Y; Luteal regression; Steroidogenesis;
Ovarian hyperstimulation syndrome
Keywords: ART; classification; IVF; management; OHSS; prevention; risk factors;
The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35Â h later for the prevention of OHSS
Keywords: OHSS; GnRH agonist trigger; Dual trigger; Low dose hCG; PCOS; IVF;
Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome
Keywords: BMI; Body mass index; CRP; C-reactive protein; E2; Estradiol; ELISA; The enzyme-linked immunosorbent assay; FBG; Fasting plasma glucose; FF; Follicular fluid; FIN; Fasting blood insulin; FSH; Follicle-stimulating hormone; GCs; Granulosa cells; GnRHant; Go
ReviewGonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art
Keywords: GnRH agonist; Luteal phase support; hCG; In vitro fertilization; OHSS;
Combining several interventions to reduce the incidence of OHSS: A prospective cohort study
Keywords: OHSS; ICSI; Cabergoline; Antagonist protocol; GnRH triggering;
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
Keywords: Antimüllerian hormone; follitropin delta; OHSS; ovarian response; pregnancy;
Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders
Keywords: IVF; GnRH agonist; OHSS; luteal support;
Early Short Stimulation Modified Natural Cycle IVF With GnRH Agonist Trigger and In Vitro Maturation in a Woman with Polycystic Ovary Syndrome: A Case Report
Keywords: In vitro maturation; IVM; GnRH agonist trigger; modified natural cycle; polycystic ovary syndrome; PCOS; ovarian hyperstimulation syndrome; OHSS; ESS; early short stimulation; GnRHa; gonadotropin-releasing hormone agonisth; CG; human chorionic gonadotrop
Electroacupuncture decreases the progression of ovarian hyperstimulation syndrome in a rat model
Keywords: electroacupuncture; hormones; inflammatory factor; OHSS; VEGF;
Opiate receptor blockade on human granulosa cells inhibits VEGF release
Keywords: granulosa cells; naloxone; OHSS; opioid receptor; OPRM1; VEGF;
Minimal stimulation IVF vs conventional IVF: a randomized controlled trial
Keywords: IVF; mini-IVF; clomiphene citrate; OHSS; multiple pregnancy;
GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis
Keywords: GnRH agonist trigger; IVF; OHSS; pregnancy rates;
Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger
Keywords: GnRH agonist triggering; final oocyte maturation; OHSS;
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
Keywords: GnRH agonist; hCG; luteal phase support; OHSS; ovulation induction
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles
Keywords: Complications; donor egg; empty follicle syndrome; fertility preservation; GnRH agonist; suboptimal response; OHSS; ovulation trigger; prevention of OHSS;
GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
Keywords: HCG; GnRH agonist; GnRH antagonist; OHSS
A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model
Keywords: OHSS; Prevention; VEGF; V1a receptor antagonist; Relcovaptan
Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization
Keywords: GnRH agonist; congenital anomalies; pregnancy outcomes; IVF; OHSS;
Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case-control study
Keywords: IVF; obstetric outcome; OHSS; pregnancy; preterm delivery;
Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders
Keywords: GnRH-agonist trigger; human chorionic gonadotropin; low-dose HCG; luteal phase support; OHSS;
GnRHa trigger for final oocyte maturation: is HCG trigger history?
Keywords: GnRHa; HCG; IVF; luteal phase support; OHSS; ovulation trigger
Coasting, embryo development and outcomes of blastocyst transfer: a case-control study
Keywords: blastocysts; coasting; live birth; IVF; OHSS;
Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists
Keywords: OHSS; VEGF; animal model; dopamine receptor 2 agonists;
Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists
Keywords: OHSS; VEGF; granulosa cells; dopamine receptor 2; dopamine receptor 2 agonist;
Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome
Keywords: VEGF; Angiogenesis; Ovary; OHSS; Apoptosis; Cell proliferation;
Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch
Keywords: IVF; OHSS; Cabergoline; Hydroxyethyl starch; Prevention;
A “freeze-all” embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?
Keywords: In vitro maturation; embryo cryopreservation; PCOS; OHSS;
Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS)
Keywords: Ovary; Angiogenesis; Angiopoietins; OHSS;
GnRH agonist triggering: recent developments
Keywords: GnRH agonist; FSH surge; LH surge; OHSS; oocyte maturation; ovulation triggering
Gonadotroph Adenoma with Secondary Hypersecretion of Testosterone
Keywords: Gonadotroph; Hypersecretion; Nonfunctioning adenoma; Pituitary; Testosterone; FSH; Follicle-stimulating hormone; LH; Luteinizing hormone; OHSS; Ovarian hyperstimulation syndrome;
Cryopréservation de la cohorte embryonnaire en cas de risque d’hyperstimulation : prévention et efficacité
Keywords: Hyperestrogénie; OHSS; Endomètre; CryopréservationHyperestrogenic state; OHSS; Endometrium; Cryopreservation
Biomarkers of ovarian response: current and future applications
Keywords: Antimüllerian hormone; antral follicle count; biomarkers; OHSS; ovarian response; ovarian stimulation
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A r
Keywords: AMH; AMH variability; excessive responders; OHSS; ovarian response; poor responder; stimulation; time interval
Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection
Keywords: Corifollitropin alfa; poor responders; OHSS; antimüllerian hormone; AMH; AFC